The device was developed to improve the delivery of therapeutic agents into a damaged spinal disc. The devices using Crosstrees Pod technology include a polymer material which is constructed to control the delivery of biomaterials to the body, focusing on treating degenerative spine conditions.
The Crosstrees Pod System is being evaluated in an IDE clinical study for future clearance by the Food and Drug Administration.
Related Articles on Spine Devices:
Pioneer Surgical Technology’s Biologics Expand to Europe With Cervical Cage
Captiva Spine Ramping Up Production of TLIF Device After Receiving Patents
Integra LifeSciences Launches Anterior Cervical Fixation System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.